De-risk your project
A promising medtech or life science project needs more than a great idea, it needs a clear path forward. De-risking helps you identify challenges early and make informed decisions fast. From preliminary clinical validation to biocompatibility studies and regulatory assessments, we support you in tackling key uncertainties with up to CHF 30K in funding.
(c) EPFL 2025 – The microorganisms in our intestines play an important role in many bodily processes, from digestion to emotions, and are a key factor in our overall health. A number of modern diseases could be traced to disturbances in the gut microbiome. Camille Goemans Lab of Drug-microbiota Interactions EPFL
De-risk your project in Life Sciences and Medtech
For your life science or medtech project to succeed, de-risking is a fundamental step. Move from bench to market with confidence.
- Why
- Getting purposeful and tangible feedback on project feasibility is key for moving in the right direction, fast. De-risking will help you analyse and assess potential challenges and opportunities and help you make the right decisions at the right time.
- Who
- You are incubating a startup project in an EPFL lab. You have a clear roadmap to take you from bench to market. You have identified the main threats to the project and have a mitigation plan in place.
- What
- De-risking takes many forms. We are currently funding projects such as preliminary clinical validation, material biocompatibility or toxicity studies, and regulatory assessments. We can contribute up to CHF 30K towards these projects.
- When
- You tell us! When you have identified your pain point and de-risking is essential to move your project forward.
- How can I find out more
- Get in touch by filling the form hereafter – together with the Startup Launhpad, we’ll discuss how we can support you with de-risking your project.